Fol. Biol. 2020, 66, 133-141

https://doi.org/10.14712/fb2020066040133

The Von Willebrand Factor Antigen Plasma Concentration: a Monitoring Marker in the Treatment of Aortic and Mitral Valve Diseases

M. A. Perrone1, F. G. Viola2, M. Minieri2,3, S. Caporali4, A. Copponi2, G. Sancesario2, S. Angeletti5, R. Massoud2,3, F. Romeo1,2, Sergio Bernardini2,3, Alessandro Terrinoni3

1Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
2Unit of Laboratory Medicine, Policlinico Tor Vergata, Rome, Italy
3Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy
4Department of Industrial Engineering, University of Rome Tor Vergata, Rome, Italy
5Unit of Clinical Laboratory Science, University Campus Bio-Medico of Rome, Rome, Italy

Received November 2019
Accepted July 2020

References

1. Anderson, R. P., McGrath, K., Street, A. (1996) Reversal of aortic stenosis, bleeding gastrointestinal angiodysplasia, and von Willebrand syndrome by aortic valve replacement. Lancet 347, 689-690. <https://doi.org/10.1016/S0140-6736(96)91240-4>
2. Coppola, D., Abbruzzetti, S., Nicoletti, F., Merlino, A., Gambacurta, A., Giordano, D., Howes, B. D., De Sanctis, G., Vitagliano, L., Bruno, S., di Prisco, G., Mazzarella, L., Smulevich, G., Coletta, M., Viappiani, C., Vergara, A., Verde, C. (2012) ATP regulation of the ligand-binding properties in temperate and cold-adapted haemoglobins. X-ray structure and ligand-binding kinetics in the sub-Antarctic fish Eleginops maclovinus. Mol. Biosyst. 8, 3295-3304. <https://doi.org/10.1039/c2mb25210d>
3. Cribier, A., Eltchaninoff, H., Bash, A., Borenstein, N., Tron, C., Bauer, F., Derumeaux, G., Anselme, F, Laborde, F., Leon, M. B. (2002) Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106, 3006-3008. <https://doi.org/10.1161/01.CIR.0000047200.36165.B8>
4. Denis, C. V., Christophe, O. D., Oortwijn, B. D., Lenting, P. J. (2008) Clearance of von Willebrand factor. Thromb. Haemost. 99, 271-278.
5. Federici, A. B., Rand, J. H., Bucciarelli, P., Budde, U., van Genderen, P. J., Mohri, H., Meyer, D., Rodeghiero, F., Sadler, J. E., Subcommittee on von Willebrand, F. (2000) Acquired von Willebrand syndrome: data from an international registry. Thromb. Haemost. 84, 345-349.
6. Federici, A. B. (2006) Acquired von Willebrand syndrome: an underdiagnosed and misdiagnosed bleeding complication in patients with lymphoproliferative and myeloproliferative disorders. Semin. Hematol. 43, S48-58. <https://doi.org/10.1053/j.seminhematol.2005.11.003>
7. Fisher, A. B., Chien, S., Barakat, A. I., Nerem, R. M. (2001) Endothelial cellular response to altered shear stress. Am. J. Physiol. Lung Cell. Mol. Physiol. 281, L529-533. <https://doi.org/10.1152/ajplung.2001.281.3.L529>
8. Franchini, M., Lippi, G. (2007) Acquired von Willebrand syndrome: an update. Am. J. Hematol. 82, 368-375. <https://doi.org/10.1002/ajh.20830>
9. Koscielny, J. (2009) Bleeding and thromboembolic risk. Perioperative strategy in aspirin/clopidogrel. Pharm. Unserer Zeit 38, 352-358. (in German) <https://doi.org/10.1002/pauz.200900325>
10. Ledford-Kraemer, M. R. (2010) Analysis of von Willebrand factor structure by multimer analysis. Am. J. Hematol. 85, 510-514. <https://doi.org/10.1002/ajh.21739>
11. Lenting, P. J., Westein, E., Terraube, V., Ribba, A. S., Huizinga, E. G., Meyer, D., de Groot, P. G., Denis, C. V. (2004) An experimental model to study the in vivo survival of von Willebrand factor. Basic aspects and application to the R1205H mutation. J. Biol. Chem. 279, 12102-12109. <https://doi.org/10.1074/jbc.M310436200>
12. Lison, S., Dietrich, W., Spannagl, M. (2012) Review article: unexpected bleeding in the operating room: the role of acquired von Willebrand disease. Anesth. Analg. 114, 73-81. <https://doi.org/10.1213/ANE.0b013e318236b16a>
13. Maganti, K.; Rigolin, V. H.; Sarano, M. E.; Bonow, R. O. (2010) Valvular heart disease: diagnosis and management. Mayo Clin. Proc 85, 483-500. <https://doi.org/10.4065/mcp.2009.0706>
14. Mehta, R., Athar, M., Girgis, S., Hassan, A., Becker, R. C. (2019) Acquired Von Willebrand Syndrome (AVWS) in cardiovascular disease: a state of the art review for clinicians. J. Thromb. Thrombolysis 48, 14-26. <https://doi.org/10.1007/s11239-019-01849-2>
15. Mendolicchio, G. L., Ruggeri, Z. M. (2005) New perspectives on von Willebrand factor functions in hemostasis and thrombosis. Semin. Hematol. 42, 5-14. <https://doi.org/10.1053/j.seminhematol.2004.09.006>
16. Mohri, H. (2003) Acquired von Willebrand syndrome: its pathophysiology, laboratory features and management. J. Thromb. Thrombolysis 15, 141-149. <https://doi.org/10.1023/B:THRO.0000011369.70824.e6>
17. O’Brien, J. R., Etherington, M. D. (1992) Heart valve stenosis and von Willebrand’s factor multimers. Lancet 340, 616. <https://doi.org/10.1016/0140-6736(92)92155-9>
18. Ott, H. W., Griesmacher, A., Schnapka-Koepf, M., Golderer, G., Sieberer, A., Spannagl, M., Scheibe, B., Perkhofer, S., Will, K., Budde, U. (2010) Analysis of von Willebrand factor multimers by simultaneous high- and low-resolution vertical SDS-agarose gel electrophoresis and Cy5-labeled antibody high-sensitivity fluorescence detection. Am. J. Clin. Pathol. 133, 322-330. <https://doi.org/10.1309/AJCPZSBTD2BWOMVL>
19. Pregowski, J., Witkowski, A. (2013) Percutaneous treatment of mitral regurgitation with MitraClip device. Advances in Interventional Cardiology/Postepy Kardiol. Interwencyjnej 9, 383-389. (in Polish) <https://doi.org/10.5114/pwki.2013.38869>
20. Ruggeri, Z. M. (2002) Platelets in atherothrombosis. Nat. Med. 8, 1227-1234. <https://doi.org/10.1038/nm1102-1227>
21. Salomon, N. W., Stinson, E. B., Oyer, P., Copeland, J. G., Shumway, N. E. (1978) Operative treatment of congenital aortic stenosis. Ann. Thorac. Surg. 26, 452-460. <https://doi.org/10.1016/S0003-4975(10)62925-6>
22. Sambu, N., Curzen, N. (2010) Transcatheter aortic valve implantation: the state of play. Future Cardiol. 6, 243-254. <https://doi.org/10.2217/fca.10.3>
23. Solomon, C., Budde, U., Schneppenheim, S., Czaja, E., Hagl, C., Schoechl, H., von Depka, M., Rahe-Meyer, N. (2011) Acquired type 2A von Willebrand syndrome caused by aortic valve disease corrects during valve surgery. Br. J. Anaesth. 106, 494-500. <https://doi.org/10.1093/bja/aeq413>
24. Stewart, M. H., Jenkins, J. S. (2016) The evolving role of percutaneous mitral valve repair. Ochsner J. 16, 270-276.
25. Tiede, A., Priesack, J., Werwitzke, S., Bohlmann, K., Oortwijn, B., Lenting, P., Eisert, R., Ganser, A., Budde, U. (2008) Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single-centre cohort study. J. Thromb. Haemost. 6, 569-576. <https://doi.org/10.1111/j.1538-7836.2008.02909.x>
26. Tiede, A., Rand, J. H., Budde, U., Ganser, A., Federici, A. B. (2011) How I treat the acquired von Willebrand syndrome. Blood 117, 6777-6785. <https://doi.org/10.1182/blood-2010-11-297580>
27. Tiede, A. (2012) Diagnosis and treatment of acquired von Willebrand syndrome. Thromb. Res. 130 (Suppl 2), S2-6. <https://doi.org/10.1016/S0049-3848(13)70003-3>
28. Tsai, H. M. (2003) Shear stress and von Willebrand factor in health and disease. Semin. Thromb. Hemost. 29, 479-488.
29. Van Belle, E., Rauch, A., Vincentelli, A., Jeanpierre, E., Legendre, P., Juthier, F., Hurt, C., Banfi, C., Rousse, N., Godier, A., Caron, C., Elkalioubie, A., Corseaux, D., Dupont, A., Zawadzki, C., Delhaye, C., Mouquet, F., Schurtz, G., Deplanque, D., Chinetti, G., Staels, B., Goudemand, J., Jude, B., Lenting, P. J., Susen, S. (2015) Von Willebrand factor as a biological sensor of blood flow to monitor percutaneous aortic valve interventions. Circ. Res. 116, 1193-1201. <https://doi.org/10.1161/CIRCRESAHA.116.305046>
30. Velik-Salchner, C., Eschertzhuber, S., Streif, W., Hangler, H., Budde, U., Fries, D. (2008) Acquired von Willebrand syndrome in cardiac patients. J. Cardiothorac. Vasc. Anesth. 22, 719-724. <https://doi.org/10.1053/j.jvca.2007.05.013>
31. Veyradier, A., Jenkins, C. S., Fressinaud, E., Meyer, D. (2000) Acquired von Willebrand syndrome: from pathophysiology to management. Thromb. Haemost. 84, 175-182. <https://doi.org/10.1055/s-0037-1613993>
32. Vincentelli, A., Susen, S., Le Tourneau, T., Six, I., Fabre, O., Juthier, F., Bauters, A., Decoene, C. Goudemand, J., Prat, A., Jude, B. (2003) Acquired von Willebrand syndrome in aortic stenosis. N. Engl. J. Med. 349, 343-349. <https://doi.org/10.1056/NEJMoa022831>
33. Zheng, X., Chung, D., Takayama, T. K., Majerus, E. M., Sadler, J. E., Fujikawa, K. (2001) Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J. Biol. Chem. 276, 41059-41063. <https://doi.org/10.1074/jbc.C100515200>
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive